
Journal of Medicinal Chemistry p. 1440 - 1445 (1981)
Update date:2022-08-03
Topics:
Neumeyer, John L.
Arana, George W.
Law, Say-Jong
Lamont, Jeffrey S.
Kula, Nora S.
Baldessarini, Ross J.
The presence of the A ring of aporphines and the addition of substituents to it and to other portions of the aporphine ring systems can extend explorations of the dimensions and other characteristics of the dopamine receptor.Accordingly, the synthesis and some physical and pharmacological properties of a series of (-)-2,10,11-trihydroxyaporphines (3a-g) are described.Structure-activity relationships among mono-, di-, and trihydroxyaporphines were evaluated against the high-affinity (nanomolar) binding of <3H>apomorphine (APO) and <3H>spiroperidol (SPR) with a subcellular fraction (P4) of caudate nucleus from bovine brain.In addition, DA-sensitive adenylate cyclase activity was evaluated in homogenates of rat brain striatal tissue.The rank order of displacement of <3H>APO by potent aporphines (IC50<*>30 nM) correlated approximately with their ability to stimulate cyclic AMP synthesis.Potency orders against the two ligands were dissimilar; for example, increasing the size of N6-alkyl substituents increased potency vs. <3H>SPR but not vs. <3H>APO binding.Moreover, <3H>SPR binding correlated poorly with cyclase activity or <3H>APO binding, suggesting a closer relationship of <3H>APO binding to dopamine-sensitive adenylate cyclase activity.
View MoreHangzhou Dingyan Chem Co., Ltd
website:http://www.dingyanchem.com
Contact:86-571-87157530
Address:RM.1118,NO.1 Building, Baiyun Tower,Jianggan Area, Hangzhou city, China,310004
Contact:+33-5-34012600
Address:28 ZA des Pignès
Contact:+86-21-56338808
Address:799 Dunhuang Road, Putuo
Shanghai Micro-mega Industry Co., Ltd.
Contact:0086-21-34628682;57153848
Address:Rm413,No.413,West Meilong Road, Minhang District,Shanghai P R China
Tianjin SPHINX SCIENTIFIC LAB.
Contact:+86-022-66211289
Address:Tianda high-tech Park. No.80,the 4th Avenue
Doi:10.1039/b008476j
(2001)Doi:10.1002/1521-4184(200102)334:2<62::AID-ARDP62>3.0.CO;2-G
(2001)Doi:10.1002/ejoc.201403083
(2014)Doi:10.1016/j.tet.2015.02.034
(2015)Doi:10.1016/S0040-4039(01)86156-6
(1979)Doi:10.1007/BF01169263
(1996)